Lentinan, A Shiitake Mushroom ò-Glucan, Stimulates Tumor-Specific Adaptive Immunity through PD-L1 Down-Regulation in Gastric Cancer Cells

@article{Ina2016LentinanAS,
  title={Lentinan, A Shiitake Mushroom {\~A}{\^A}²-Glucan, Stimulates Tumor-Specific Adaptive Immunity through PD-L1 Down-Regulation in Gastric Cancer Cells},
  author={Hiroko Ina and M. Yoneda and K. Mitsuro and Y. Kodera and M. Kabeya and S. Yuasa and T. Kataoka and R. Furuta and K. Ina},
  journal={Medicinal Chemistry},
  year={2016},
  volume={6},
  pages={710-714}
}
Background: Despite the significant advances in chemotherapy, the prognosis of unresectable gastric cancer is still very poor and the role of immunotherapy remains to be clarified. We examined whether lentinan, a biological response modifier, could enhance the chemotherapeutic effects. Materials and methods: A retrospective cohort study was conducted to evaluate the survival benefits of lentinan among the patients with gastric cancer receiving chemotherapy. To investigate the mechanisms… Expand
2 Citations

References

SHOWING 1-10 OF 40 REFERENCES
The Use of Lentinan for Treating Gastric Cancer
The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk /MAPK signaling pathway.
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.
Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Oncology meets immunology: the cancer-immunity cycle.
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
β-Glucans and their applications in cancer therapy: focus on human studies.
  • E. Aleem
  • Biology, Medicine
  • Anti-cancer agents in medicinal chemistry
  • 2013
...
1
2
3
4
...